|
1
|
Lin PL and Flynn JL: Understanding latent
tuberculosis: A moving target. J Immunol. 185:15–22. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Oxlade O, Schwartzman K, Behr MA,
Benedetti A, Pai M, Heymann J and Menzies D: Global tuberculosis
trends: A reflection of changes in tuberculosis control or in
population health? Int J Tuberc Lung Dis. 13:1238–1246.
2009.PubMed/NCBI
|
|
3
|
Zumla A, George A, Sharma V and Herbert N;
Baroness Masham of Ilton: WHO's 2013 global report on tuberculosis:
Successes, threats, and opportunities. Lancet. 382:1765–1767. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Stark GR: How cells respond to interferons
revisited: From early history to current complexity. Cytokine
Growth Factor Rev. 18:419–423. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lee J and Kornfeld H: Interferon-γ
regulates the death of M. tuberculosis-infected macrophages. J Cell
Death. 3:1–11. 2010.PubMed/NCBI
|
|
6
|
Ottenhoff TH, Kumararatne D and Casanova
JL: Novel human immunodeficiencies reveal the essential role of
type-I cytokines in immunity to intracellular bacteria. Immunol
Today. 19:491–494. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Naderi M, Hashemi M, Rezaei M and Safdari
A: Association of genetic polymorphisms of IFNGR1 with the risk of
pulmonary tuberculosis in Zahedan, Southeast Iran. Tuberc Res
Treat. 2015:2925052015.PubMed/NCBI
|
|
8
|
Hashemi M, Sharifi-Mood B, Nezamdoost M,
Moazeni-Roodi A, Naderi M, Kouhpayeh H, Taheri M and Ghavami S:
Functional polymorphism of interferon-γ (IFN-γ) gene +874T/A
polymorphism is associated with pulmonary tuberculosis in Zahedan,
Southeast Iran. Prague Med Rep. 112:38–43. 2011.PubMed/NCBI
|
|
9
|
Seyfried NT, Huysentruyt LC, Atwood JA
III, Xia Q, Seyfried TN and Orlando R: Up-regulation of NG2
proteoglycan and interferon-induced transmembrane proteins 1 and 3
in mouse astrocytoma: A membrane proteomics approach. Cancer Lett.
263:243–252. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Fan J, Peng Z, Zhou C, Qiu G, Tang H, Sun
Y, Wang X, Li Q, Le X and Xie K: Gene-expression profiling in
Chinese patients with colon cancer by coupling experimental and
bioinformatic genomewide gene-expression analyses: Identification
and validation of IFITM3 as a biomarker of early colon
carcinogenesis. Cancer. 113:266–275. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Brass AL, Huang IC, Benita Y, John SP,
Krishnan MN, Feeley EM, Ryan BJ, Weyer JL, van der Weyden L, Fikrig
E, et al: The IFITM proteins mediate cellular resistance to
influenza A H1N1 virus, West Nile virus, and dengue virus. Cell.
139:1243–1254. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Jiang D, Weidner JM, Qing M, Pan XB, Guo
H, Xu C, Zhang X, Birk A, Chang J, Shi PY, et al: Identification of
five interferon-induced cellular proteins that inhibit west nile
virus and dengue virus infections. J Virol. 84:8332–8341. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Weidner JM, Jiang D, Pan XB, Chang J,
Block TM and Guo JT: Interferon-induced cell membrane proteins,
IFITM3 and tetherin, inhibit vesicular stomatitis virus infection
via distinct mechanisms. J Virol. 84:12646–12657. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lange UC, Saitou M, Western PS, Barton SC
and Surani MA: The fragilis interferon-inducible gene family of
transmembrane proteins is associated with germ cell specification
in mice. BMC Dev Biol. 3:12003. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Stein CM, Zalwango S, Malone LL, Won S,
Mayanja-Kizza H, Mugerwa RD, Leontiev DV, Thompson CL, Cartier KC,
Elston RC, et al: Genome scan of M. tuberculosis infection and
disease in Ugandans. PLoS One. 3:e40942008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Shen C, Wu XR, Jiao WW, Sun L, Feng WX,
Xiao J, Miao Q, Liu F, Yin QQ, Zhang CG, et al: A functional
promoter polymorphism of IFITM3 is associated with susceptibility
to pediatric tuberculosis in Han Chinese population. PLoS One.
8:e678162013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hashemi M, Sharifi-Mood B, Rasouli A,
Amininia S, Naderi M and Taheri M: Macrophage migration inhibitory
factor −173 G/C polymorphism is associated with an increased risk
of pulmonary tuberculosis in Zahedan, Southeast Iran. EXCLI J.
14:117–122. 2015.PubMed/NCBI
|
|
18
|
Naderi M, Hashemi M, Taheri M, Pesarakli
H, Eskandari-Nasab E and Bahari G: CD209 promoter −336 A/G
(rs4804803) polymorphism is associated with susceptibility to
pulmonary tuberculosis in Zahedan, southeast Iran. J Microbiol
Immunol Infect. 47:171–175. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Naderi M, Hashemi M, Pourmontaseri Z,
Eskandari-Nasab E, Bahari G and Taheri M: TIRAP rs8177374 gene
polymorphism increased the risk of pulmonary tuberculosis in
Zahedan, southeast Iran. Asian Pac J Trop Med. 7:451–455. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Naderi M, Hashemi M, Hazire-Yazdi L,
Taheri M, Moazeni-Roodi A, Eskandari-Nasab E and Bahari G:
Association between toll-like receptor2 Arg677Trp and 597T/C gene
polymorphisms and pulmonary tuberculosis in Zahedan, Southeast
Iran. Braz J Infect Dis. 15:516–520. 2013. View Article : Google Scholar
|
|
21
|
Hashemi M, Eskandari-Nasab E,
Moazeni-Roodi A, Naderi M, Sharifi-Mood B and Taheri M: Association
of CTSZ rs34069356 and MC3R rs6127698 gene polymorphisms with
pulmonary tuberculosis. Int J Tuberc Lung Dis. 17:1224–1228. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Naderi M, Hashemi M and Amininia S:
Association of TAP1 and TAP2 Gene Polymorphisms with Susceptibility
to Pulmonary Tuberculosis. Iran J Allergy Asthma Immunol. 15:62–68.
2016.PubMed/NCBI
|
|
23
|
Bahari G, Hashemi M, Taheri M, Naderi M,
Eskandari-Nasab E and Atabaki M: Association of IRGM polymorphisms
and susceptibility to pulmonary tuberculosis in Zahedan, Southeast
Iran. Sci World J. 2012:9508012012. View Article : Google Scholar
|
|
24
|
Hashemi M, Bojd H Hanafi, Nasab E
Eskandari, Bahari A, Hashemzehi NA, Shafieipour S, Narouie B,
Taheri M and Ghavami S: Association of Adiponectin rs1501299 and
rs266729 Gene Polymorphisms With Nonalcoholic Fatty Liver Disease.
Hepat Mon. 13:e95272013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Everitt AR, Clare S, Pertel T, John SP,
Wash RS, Smith SE, Chin CR, Feeley EM, Sims JS, Adams DJ, et al:
MOSAIC Investigators: IFITM3 restricts the morbidity and mortality
associated with influenza. Nature. 484:519–523. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Feeley EM, Sims JS, John SP, Chin CR,
Pertel T, Chen LM, Gaiha GD, Ryan BJ, Donis RO, Elledge SJ, et al:
IFITM3 inhibits influenza A virus infection by preventing cytosolic
entry. PLoS Pathog. 7:e10023372011. View Article : Google Scholar : PubMed/NCBI
|
